ENCAPSID Study : ENCApsulated Bacterial Infection and Primary, Secondary ImmunoDeficiency

计划入组 50 人 · 首次发布于 2018 年 10 月 26 日

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

计划入组 75 人 · 首次发布于 2023 年 5 月 30 日

Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.

计划入组 36 人 · 首次发布于 2020 年 4 月 21 日

intravenous immunoglobulin (primary immunodeficiency disease)

HIV specific T-cell therapy

Env 2-3

Theratechnologies

Ridgestone Mining Inc

United States

Cornerstone Total Return Fund Inc

Grifols Doses First Patients in Two Phase 3 Trials to Expand Labels for Gamunex-C and Xembify

Takeda's HYQVIA Approved in Japan for Agammaglobulinemia and Hypogammaglobulinemia

Subcutaneous Immunoglobulin 20% Effective for Primary Immunodeficiency